Hoth Therapeutics Stock Investor Sentiment

HOTH Stock  USD 1.11  0.02  1.83%   
Under 50% of Hoth Therapeutics' traders are presently thinking to get in. The analysis of overall sentiment of trading Hoth Therapeutics stock suggests that some investors are interested at this time. Hoth Therapeutics' investing sentiment shows overall attitude of investors towards Hoth Therapeutics.
  

Hoth Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Hoth Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at news.google.com         
Acquisition or disposition of Hoth Therapeutics securities by Sarnoff David
Google News at Macroaxis
over a year ago at investing.com         
Hoth Therapeutics stock gets Buy rating as it meets unmet medical needs
Investing News at Macroaxis
over a year ago at thelincolnianonline.com         
Hoth Therapeutics Research Coverage Started at HC Wainwright
news
over a year ago at seekingalpha.com         
Hoth stock jumps on FDA approval of study expansion for HT-001
seekingalpha News
over a year ago at finance.yahoo.com         
Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severe...
Yahoo News
over a year ago at marketwatch.com         
Hoth Therapeutics Shares Rise 14 percent After FDA Clearance for HT-001 Trial Amendments
marketwatch News
over a year ago at www.macroaxis.com         
Acquisition by Robb Knie of 225000 shares of Hoth Therapeutics subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Premarket Mover Hoth Therapeutics Inc Down 4.35 percent - InvestorsObserver
Google News at Macroaxis
over a year ago at benzinga.com         
Why Hoth Therapeutics Shares Are Rising Today
benzinga news
over a year ago at finance.yahoo.com         
Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patien...
Yahoo News
over a year ago at news.google.com         
Do Traders Think Hoth Therapeutics Inc Can Turn Around Thursday - InvestorsObserver
Google News at Macroaxis
over a year ago at finance.yahoo.com         
The HOTH Introduces Revolutionary Financing Option for SEO Services
Yahoo News
over a year ago at news.google.com         
Should You Accumulate Hoth Therapeutics Inc Stock Wednesday Morning - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Hoth Therapeutics Announces it Has Successfully Completed ... - Marketscreener.com
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Hoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KI...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Hoth Therapeutics that are available to investors today. That information is available publicly through Hoth media outlets and privately through word of mouth or via Hoth internal channels. However, regardless of the origin, that massive amount of Hoth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hoth Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hoth Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hoth Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hoth Therapeutics alpha.

Hoth Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of tradable shares by Hayes Anthony of Hoth Therapeutics subject to Rule 16b-3
12/20/2024
2
Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment
12/26/2024
3
Hoth Therapeutics Soars 215 percent on Breakthrough Cancer Treatment Success
01/07/2025
4
Acquisition by Springer Graig of 70000 shares of Hoth Therapeutics at 1.55 subject to Rule 16b-3
01/14/2025
5
Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025
01/17/2025
6
Hoth Therapeutics regains compliance with Nasdaq
01/24/2025
7
Hoth Therapeutics Partners with OnTargetx RD to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic
02/10/2025
8
Acquisition by Springer Graig of 33000 shares of Hoth Therapeutics at 2.11 subject to Rule 16b-3
02/18/2025
9
Insider Trading
02/26/2025
10
Hoth Therapeutics Announces Positive Results for HT-001 in Treating EGFR Inhibitor-Associated Papulopustular Eruptions Findings to be Presented at the American ...
03/05/2025
11
Hoth Therapeutics Receives Buy Rating from D. Boral Capital - Defense World
03/11/2025

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bonds Directory
Find actively traded corporate debentures issued by US companies